Charlottetown, PE – The Canadian Alliance for Skills and Training in Life Sciences (CASTL) is excited to announce the launch of a new course, "Essentials of Viral Safety and Clearance," offered in partnership with Asahi KASEI BIOPROCESS (AKB). Scheduled for November 8, 2024, at the CASTL Biomanufacturing Training Facility in Montreal, QC, this course offers a comprehensive exploration of viral contamination risks and the methodologies essential for maintaining the safety and efficacy of biopharmaceuticals.
Participants will benefit from practical, hands-on experience with cutting-edge tools and techniques under the expert guidance of AKB Senior Laboratory Manager, Don Gibbs.
|
Viral safety is critical in biopharmaceutical production. Our partnership with global leader Asahi KASEI BIOPROCESS enables us to deliver a course that tackles the industry’s real-world challenges. This initiative represents a significant step forward in equipping professionals with the advanced skills necessary to advance their careers and ensure the safety of life-saving products. Sven Ansorge |
Asahi KASEI BIOPROCESS, renowned for its expertise in viral safety, brings decades of experience to this program, guaranteeing participants access to the most thorough and up-to-date training available. The course will address crucial topics such as viral risk assessment, clearance strategies, and regulatory expectations, making it indispensable for process development, quality control, and regulatory affairs professionals.
|
As a global leader in viral safety, Asahi KASEI BIOPROCESS is pleased to partner with CASTL to deliver this essential training. We are confident that this course will provide participants with the knowledge and practical skills they need to navigate the complexities of viral safety in biopharmaceutical manufacturing. Our joint commitment to advancing the industry through education and innovation is reflected in this partnership. Don Gibbs |
The "Essentials of Viral Safety and Clearance" course underscores CASTL’s dedication to delivering high-quality, hands-on training that addresses the evolving needs of Canada’s life sciences sector.
For more information about the course and to register, please visit CASTL's training calendar.
-30-
Media Inquiries:
Heidi Reinblatt
Director of Marketing and Communications, CASTL
heidi@castlcanada.ca
514-944-3487
About CASTL
The Canadian Alliance for Skills and Training in Life Sciences (CASTL) is a national skills and training organization formed to address the talent needs of the Canadian life sciences sector. Specializing in biopharmaceutical manufacturing, CASTL delivers on the economic and sectoral demand for individuals who have the technical skills to enter, thrive in and meet the needs of the fast-growing Canadian biomanufacturing industry. With multiple GMP-simulated biomanufacturing training facilities in Charlottetown, PE, Montreal, QC, and coming soon to Richmond, BC, CASTL provides industry-informed, hands-on training, theoretical knowledge, and e-learning.
CASTL is the exclusive provider of the National Institute for Bioprocessing Research and Training (NIBRT) licensed training programs in Canada. Based in Ireland, the NIBRT develops and delivers state-of-the-art training and education programs for the world’s leading biopharmaceutical manufacturing companies and partner academic institutions. CASTL is supported by adMare BioInnovations and its adMare Academy. The adMare Academy provides the specialized training required to foster the next generation of highly qualified personnel who will drive the growth of Canadian life science companies www.castlcanada.ca.
About Asahi KASEI BIPROCESS
Asahi KASEI BIOPROCESS, a division of Asahi Kasei Medical, supplies innovative bioprocessing tools and services that enhance the safety, manufacturing efficiency, and purity of modern biotherapeutics and pharmaceuticals. With offerings in purification, fluid management solutions, contract manufacturing, and pathogen safety testing services, Asahi Kasei Bioprocess provides a growing set of technologies that enable manufacturers of regulated therapeutics to safely and efficiently produce medicines that patients can trust.
To learn more about how Asahi Kasei Bioprocess upholds our commitment of “Pioneering Biologics Safety and Manufacturing Efficiency,” please visit www.ak-bio.com.
.svg)
.svg)
(1).svg)
